Solventum (MEX:SOLV) EBITDA Margin % : 13.01% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Solventum EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Solventum's EBITDA for the three months ended in Dec. 2024 was MXN5,631 Mil. Solventum's Revenue for the three months ended in Dec. 2024 was MXN43,276 Mil. Therefore, Solventum's EBITDA margin for the quarter that ended in Dec. 2024 was 13.01%.

Solventum EBITDA Margin % Historical Data

The historical data trend for Solventum's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum EBITDA Margin % Chart

Solventum Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EBITDA Margin %

27.87

30.30

27.92

27.18

18.50

Solventum Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBITDA Margin %	Get a 7-Day Free Trial						26.03	25.15	16.48	19.55	13.01

Competitive Comparison of Solventum's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Solventum's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Solventum's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Solventum's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Solventum's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Solventum EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Solventum's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	31846.654	/	172142.948
	=	18.50 %

Solventum's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	5631.039	/	43275.577
	=	13.01 %

Solventum (MEX:SOLV) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Solventum EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Solventum's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Solventum Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (MEX:SOLV) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

SOLV:USA KB7:Germany

Address

2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144

Website

https://www.solventum.com/en-us/home

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.